Elimination and Eradication of Malaria: Nigeria in Perspective
Eradication globally is the current goal for malaria control by eliminating the disease locally in all countries where it is endemic [1,2], but plasmodium species continue to evolve different survival mechanisms including development of resistance to all class of antimalarial drugs [1,3]. In Africa, Plasmodium falciparum infection; which causes the most virulent form of malaria, is highly endemic because of the favorable existence of competent species of mosquito vectors that effectively transmit the disease [3]. The World Malaria report 2018 indicates that there is a stalled progress in reduction of malaria incidence in the African region within the past few years. This notwithstanding, some countries recently have achieved the elimination status for malaria control in other regions while others reported reduced incidence [4].
Mini Review
Eradication globally is the current goal for malaria control by eliminating the disease locally in all countries where it is endemic [1, 2], but plasmodium species continue to evolve different survival mechanisms including development of resistance to all class of antimalarial drugs [1, 3]. In Africa, Plasmodium falciparum infection; which causes the most virulent form of malaria, is highly endemic because of the favorable existence of competent species of mosquito vectors that effectively transmit the disease [3]. The World Malaria report 2018 indicates that there is a stalled progress in reduction of malaria incidence in the African region within the past few years. This notwithstanding, some countries recently have achieved the elimination status for malaria control in other regions while others reported reduced incidence [4].
Cues from such nations can be used to reproduce similar effective reduction in Africa but notably, there are differences in environmental factors, control strategies and implementation by governmental structures between these countries. Nigeria is the most populous African nation with projected population size of over 200 million people. Nigeria had the highest burden of malaria from the world malaria report of 2018 bearing a quarter of the global malaria incidence globally in 2017 [4]. This is alarming as malaria trend in Nigeria continues to be sustained, hence there is need to evaluate the impact of control strategies [5], as multiple approaches are required to effectively eradicate the disease [4]. There is a need for a more holistic approach for effective reduction of malaria in Nigeria, ultimately reducing the global incidence. This review briefly highlights current and potential strategies for eliminating malaria in Nigeria to achieve a malaria free nation.
Malaria Control in Nigeria
Many factors pose challenges for malaria elimination in Nigeria including environmental factors and insecticide resistance which limits vector control, high asymptomatic infections and parasite resistance to many antimalarials [6, 7, 8, 9, 10] Dokunmu, et al. as well as poor access to primary healthcare [11]. Some of the control measures used in Nigeria include vector control; indoor and outdoor residual spraying [6], adoption of ACTs as firstline treatment for malaria and evaluation of its efficacy [12], and inclusion of newer combinations, presumptive treatment of febrile children <5 year olds with firstline antimalarials, use of insecticide treated mosquito nets for all household, intermittent preventive treatment in pregnant women, evaluation of drug efficacy, surveillance through population-based Malaria Indicator Survey among others [3, 11, 13].
To date in Nigeria, most of these challenges persist and to overcome them, newer policies and improved implementation strategies have been set by National Malaria Elimination Program of the Federal Ministry of Health, Rollback Malaria, USAID’s President’s Malaria Initiative and other collaborating agencies, to achieve record low transmission in Nigeria by the year 2020 [11, 13]. Some of these include: making available preventive measures for malaria protection in 80% populations, mass education on prevention, malaria screening by RDTs for people seeking care and reporting of cases, effective treatment of confirmed malaria cases hospital settings, availability of effective antimalarials, etc.
Exploring New Strategies for Elimination
Routine nation-wide epidemiological surveillance is not in place yet, malaria detection in persons not seeking care - asymptomatic carriers would still be missed if this is not implemented which should be included under the malaria surveillance system. This strategy has been effective in other low endemic regions who implement mass drug administration because of minimal concern for drug resistance and associated side-effects [14, 15]. In the case of Nigeria, other new drug combinations can be explored because of resistance [16, 17] for mass drug administration in school-age children as well as older persons. It is of great importance to carry out country wide periodic malaria epidemiology to upscale surveillance for malaria elimination in Nigeria. In conclusion, Nigeria has set improved strategies for a road track to malaria elimination, but critical review of the effectiveness of these strategies is important. These strategies build on the ones previously used over the past decades, showing little progress in transmission reduction; however it is recommended that adopting different strategies as well institutional policy change can be more effective to drive malaria elimination in Nigeria.
References
-
World Health Organization (2014) Technical Expert Group on Drug Resistance and Containment 28-30 April 2014-Starling hotel, Geneva, Switzerland.
-
WHO (2016) Eliminating malaria. World Health Organization, Geneva.
-
Peter B Bloland (2001) Drug resistance in malaria. World Health Organisation, pp: 27.
-
WHO (2018a) World malaria report 2018. World Health Organization, Geneva.
-
Griffin JT, Hollingsworth TD, Okell LC, Churcher TS, White M, et al. (2010) Reducing Plasmodium falciparum malaria transmission in Africa: a model- based evaluation of intervention strategies. PLoS Med 7(8): e1000324.
-
Federal Ministry of Health (2008) National malaria and vector control programme, training manual for management of malaria in Nigeria. Kaduna, Nigeria.
-
Happi CT, Gbotosho GO, Folarin OA, Sowunmi A, Hudson T, et al. (2009) Selection of Plasmodium falciparum multidrug resistance gene1 alleles in asexual stages and gametocytes by artemether- lumefantrine in Nigerian children with uncomplicated falciparum malaria. Antimicrob Agents Chemother 53(3): 888-895.
-
Bustamante C, Folarin OA, Gbotosho GO, Batista CN, Mesquita EA, et al. (2012) In-vitro reduced susceptibility to artemether in P. falciparum and its association with polymorphisms on transporter genes. J Infect Dis 206(3): 324-332.
-
Oladipo OO, Wellington OA, Sutherland CJ (2015) Persistence of chloroquine-resistant haplotypes of Plasmodium falciparum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine. Diagnostic Path 10: 41
-
Kamau E, Campino S, Amenga-Etego L, Drury E, Ishengoma D, et al. (2015) K13-propeller polymorphisms in Plasmodium falciparum parasites from sub-Saharan Africa. J Infect Dis 211(8): 1352- 1355.
-
National Malaria Elimination Programme (NMEP), National Population Commission (NPopC), National Bureau of Statistics (NBS), and ICF International (2016) Nigeria Malaria Indicator Survey 2015. Abuja, Nigeria, and Rockville, Maryland, USA: NMEP, NPopC, and ICF International.
-
WHO (2018b) Artemisinin resistance and artemisinin-based combination therapy efficacy- status report. World Health Organisation.
-
Roll back Malaria (2014) National Malaria strategic plan 2014-2020. Nigeria.
-
Newby G, Hwang J, Koita K, Chen I, Greenwood B, et al. (2015) Review of mass drug administration for malaria and its operational challenges. Amer J Trop Med Hyg 93(1): 125-134.
-
WHO (2017) Mass drug administration for falciparum malaria. A practical field manual. World Health Organisation, Geneva.
-
White NJ (2016) Can new treatment developments combat resistance in malaria?, Expert Opinion Pharmacother 17(10): 1303-1307.
-
Muhammad RH, Nock IH, Ndams IS, George JB, Deeni (2017) Distribution of pfmdr1 and pfcrt chloroquine drug resistance alleles in north-western Nigeria. Malar World J 8: 15
- Origin, Evolution, and Functional Impact of Short Insertion- Deletion Variants in Human Genomes: A Review
- Harnessing Molecular Glues for Next-Generation Vaccine, Cancer and Cardiovascular Disease Drug Development: A Comprehensive Review
- Lateral Cervical Epidermal Inclusion Cyst in a Paediatric Patient: A Rare Case Report
- Malarial Plasmodium Falciparum with Hepatitis B and C Virus Infections among Blood Donors in Ife Central Local Government Area, Ile Ife, Osun State, Nigeria
- Withanolides and Withaferin A- What’s next in Ashwagandha Research
- Designing of Dual Pulse Photoacoustic Tomography for Imaging of Drug-Response and Tumor Growth